“lymphocytic vasculitis” is not urticarial vasculitis

1

Click here to load reader

Upload: joan-guitart

Post on 19-Oct-2016

219 views

Category:

Documents


3 download

TRANSCRIPT

Page 1: “Lymphocytic vasculitis” is not urticarial vasculitis

Haur Yueh Lee, MBBS, MRCP, Shiu Ming Pang,FRCP, FAMS, and Thirumoorthy Thamotharam-pillai, FRCP, FAMS

From the Dermatology Unit, Singapore GeneralHospital, Singapore

Funding sources: None.

Conflicts of interest: None declared.

Reprint requests: Haur Yueh Lee, MBBS, MRCP,Registrar, Dermatology Unit, Singapore GeneralHospital, Outram Rd, Singapore 169608

E-mail: [email protected]

REFERENCES

1. Halevy S, Ghislain PD, Mockenhaupt M, Fagot JP, Bouwes

Bavinck JN, Sidoroff A, et al. Allopurinol is the most common

StevenseJohnson syndrome and toxic epidermal necrolysis in

Europe and Israel. J Am Acad Dermatol 2008;58:25-32.

2. Lee HY, Ariyasinghe JT, Thirumoorthy T. Allopurinol hypersensi-

tivity syndrome—A preventable severe cutaneous adverse

reaction? Singapore Med J 2008;49:384-7.

3. Hande KR, Noone RM, Stone WJ. Severe allopurinol toxicity.

Description and guidelines for prevention in patients with renal

insufficiency. Am J Med 1984;76:47-56.

4. Hung SI, Chung WH, Liou LB, Chu CC, Lin M, Huang HP, et al.

HLA-B*5801 allele as a genetic marker for severe cutaneous

adverse reactions caused by allopurinol. Proc Natl Acad Sci U S A

2005;102:4134-9.

5. Mallal S, Philips E, Carosi G, Molina JM, Workman C, Tomazic J,

et al. HLA-B*5701 screening for hypersensitivity to abacavir.

N Engl J Med 2008;358:568-79.

doi:10.1016/j.jaad.2008.02.021

Evaluation of rashes in oncology patients

To the Editor: The evaluation of rashes in oncologypatients is often challenging for the dermatologist.These patients are often immunosuppresed, at riskof innumerable infections, on numerous medica-tions (including chemotherapy), and prone to pro-tean paraneoplastic as well as organ-specificdermatoses. In addition, numerous dermatoses inthis population of patients may overlap clinicallyand histologically and/or have atypical clinicalpresentations and/or courses. For example, leuke-mia cutis may mimic a morbilliform rash or perni-osis.1,2 Add to the above the limited amount of timeallotted by the dermatologist for the review of theusually ‘‘thick’’ and often complicated medicalcharts of these patients. At the same time, oncology

J AM ACAD DERMATOL

VOLUME 59, NUMBER 2

Letters 353

‘‘Lymphocytic vasculitis’’ is not urticarialvasculitis

To the Editor: In the June 2007 issue, Lee et al1

reported 22 patients exhibiting the clinical features ofurticarial vasculitis, yet only three of the casesshowed leukocytoclastic vasculitis. The authors con-cluded that the majority of patients with clinicalfeatures of urticarial vasculitis have a lymphocytic-predominant vasculitis with eosinophils.

The cohort of patients in the study by Lee et al hadpersistent urticarial lesions lasting longer than 24hours with two of the following criteria: pain ortenderness; purpura or dusky changes; and resolu-tion with hyperpigmentation. I agree that thesecriteria define a prolonged and possibly severeurticaria, but they do not define urticarial vasculitis.Pain, tenderness, and some purpuric componentwith subsequent postinflammatory hyperpigmenta-tion can be observed in urticaria, especially when thepatient scratches the pruritic lesions. The histopath-ologic correlate of pruritus and scratching is

erythrocyte extravasation and eventual perivascularhemosiderin deposits. Yet this phenomenon doesnot qualify as a true vasculitis and must be inter-preted cautiously and correlated with the clinicalcontext.

Most of the patients in the study did not havehistologic criteria of leukocytoclastic vasculitis, norhypocomplementemia or constitutional symptoms,and therefore probably did not have urticarialvasculitis.

The proper nosology of clinical entities is crucial.Otherwise, the conclusions of the study may bewrongly interpreted as ‘‘lymphocytic vasculitis, acommon finding in urticarial vasculitis.’’

Joan Guitart, MD

Department of Dermatology, Northwestern Univer-sity Feinberg School of Medicine, Chicago,Illinois

Funding sources: None.

Conflicts of interest: None declared.

Correspondence to: Joan Guitart, MD, Departmentof Dermatology, Northwestern University Fein-berg School of Medicine, 676 N St. Clair St, Ste1600, Chicago, IL 60611

E-mail: [email protected]

REFERENCE

1. Lee JS, Loh TH, Seow SC, Tan SH. Prolonged urticaria with

purpura: the spectrum of clinical and histopathologic features

in a prospective series of 22 patients exhibiting the clinical

features of urticarial vasculitis. J Am Acad Dermatol 2007;

56:994-1005.

doi:10.1016/j.jaad.2008.02.028